Interleukin-6 trans-signalling and risk of future cardiovascular events: a new avenue for atheroprotection?
Cardiovasc Res
.
2019 Jan 1;115(1):8-9.
doi: 10.1093/cvr/cvy233.
Authors
Giuseppe Ferrante
1
,
Gianluigi Condorelli
1
Affiliation
1
Department of Cardiovascular Medicine, Humanitas Research Hospital, Humanitas University, Via Manzoni 56, Rozzano, Milan, Italy.
PMID:
30219834
DOI:
10.1093/cvr/cvy233
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Cardiovascular Diseases*
Humans
Interleukin-6*
Signal Transduction
Substances
Interleukin-6